Free Trial

State Street Corp Decreases Position in Varex Imaging Co. (NASDAQ:VREX)

Varex Imaging logo with Medical background

State Street Corp cut its position in Varex Imaging Co. (NASDAQ:VREX - Free Report) by 25.4% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,625,291 shares of the company's stock after selling 553,403 shares during the quarter. State Street Corp owned approximately 3.97% of Varex Imaging worth $19,373,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the business. Pzena Investment Management LLC grew its holdings in Varex Imaging by 51.4% in the third quarter. Pzena Investment Management LLC now owns 3,890,879 shares of the company's stock valued at $46,379,000 after purchasing an additional 1,321,666 shares during the last quarter. Jacobs Levy Equity Management Inc. acquired a new stake in Varex Imaging in the 3rd quarter valued at about $2,411,000. FMR LLC increased its holdings in Varex Imaging by 4,739.2% during the 3rd quarter. FMR LLC now owns 200,341 shares of the company's stock valued at $2,388,000 after acquiring an additional 196,201 shares in the last quarter. PDT Partners LLC purchased a new stake in shares of Varex Imaging in the third quarter valued at about $1,802,000. Finally, Rice Hall James & Associates LLC purchased a new stake in shares of Varex Imaging in the third quarter valued at about $1,150,000.

Varex Imaging Trading Up 3.2 %

Shares of VREX traded up $0.46 during trading hours on Tuesday, hitting $14.71. The stock had a trading volume of 324,174 shares, compared to its average volume of 513,958. The company's fifty day simple moving average is $14.46 and its 200 day simple moving average is $13.52. The firm has a market cap of $606.51 million, a P/E ratio of -12.57 and a beta of 0.60. Varex Imaging Co. has a 12-month low of $10.19 and a 12-month high of $21.06. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.97 and a current ratio of 3.32.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of Varex Imaging from a "hold" rating to a "buy" rating in a research note on Wednesday, November 27th.

Get Our Latest Analysis on VREX

Varex Imaging Profile

(Free Report)

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

Further Reading

Institutional Ownership by Quarter for Varex Imaging (NASDAQ:VREX)

Should You Invest $1,000 in Varex Imaging Right Now?

Before you consider Varex Imaging, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.

While Varex Imaging currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines